Understanding the SHP-2-PLCβ1 Complex in Angiotensin II Signaling
Author Information
Author(s): Lorenzo A Calò, Luciana Bordin, Paul A Davis, Elisa Pagnin, Lucia Dal Maso, Gian Paolo Rossi, Achille C Pessina, Giulio Clari
Primary Institution: Department of Clinical and Experimental Medicine, University of Padova, Italy
Hypothesis
The study investigates the role of the SHP-2-PLCβ1 complex in Angiotensin II signaling.
Conclusion
The study identifies a preformed SHP-2-PLCβ1 complex that responds to Ang II signaling, suggesting new pathways in Ang II signaling mechanisms.
Supporting Evidence
- The presence of a SHP-2-PLCβ1 complex was demonstrated via immunoprecipitation.
- Ang II treatment caused reciprocal changes in the phosphorylation of PLCβ1 and SHP-2.
- Blocking Ang II signaling with losartan reversed the phosphorylation changes.
Takeaway
This study found that two proteins, SHP-2 and PLCβ1, work together in a special way when a hormone called Angiotensin II is present, which helps our body control blood pressure.
Methodology
The study used cultured normal human fibroblasts, immunoprecipitation, and western blotting to analyze the SHP-2-PLCβ1 complex.
Limitations
The role of the SHP-2-PLCβ1 complex in Ang II signaling remains to be fully delineated.
Participant Demographics
Skin fibroblasts from 6 healthy subjects.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website